Ohio Public Employees Retirement System (OPERS)’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Ohio Public Employees Retirement System (OPERS)'s NRIX Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Nurix Therapeutics (NRIX) in Q2 2026, closing a stake of 27,150 shares — an estimated $421K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in NRIX in Q1 2021 and held it in 16 quarters. The position peaked at $974K in Q3 2022. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Nurix Therapeutics position as of Q2 2026 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 27,150 Nurix Therapeutics shares in Q2 2026, an estimated $421K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Nurix Therapeutics in Q1 2021 and held it in 16 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Nurix Therapeutics position peaked at $974K in Q3 2022.
- 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.